2020 Symposium on Substance Use Research

Core

2020 Symposium on Substance Use ResearchVirtual Conference — November 9-13, 2020


We are happy to announce that the 2020 Symposium on Substance Use Research will be co-hosted by:

The symposium will be held virtually during the week of November 9th, 2020. The digital format will include two to three daily presentation sessions and numerous networking sessions throughout the week to accommodate various schedules. Registration does not require attendance at all events, and attendees will be able to choose relevant online sessions from the conference webpage prior to participation. We hope to see you there!

This year's event will be bigger and better than ever, leveraging research, knowledge, and insight on substance use from across the country. Please return to this page for updates on the agenda.


The deadline to submit an abstract has been extended! We are accepting abstracts for the symposium's digitized short research presentations and poster session through September 25, 2020. Please reference the updated timeline towards the bottom of our call.




ABOUT OUR PARTNERSHIP:

In September 2019, two newly funded COBREs (the COBRE on Opioids and Overdose at Rhode Island Hospital and the Rural Drug Addiction Research [RDAR] COBRE at the University of Nebraska-Lincoln) began small efforts to collaborate with one another, with the intention of increasing access to research around substance use and addiction science more broadly. This started with brief phone calls between Center PIs and administrators and quickly expanded to a full-blown partnership, as we saw synergies across almost all areas of our programming. Our early goal to share more information across centers has grown into a valuable collaboration that includes hosting joint seminars, events, workshops, trainings, and most recently the upcoming symposium. Excitingly, while the organization of the symposium developed, a third collaborator soon emerged, and in August 2020 the symposium further expanded to include the expertise and support of an IDeA-CTR: the West Virginia Clinical and Translational Science Institute (WVCTSI).

This new collaborative continues to provide novel opportunities to work together on substance use-focused research and intervention development across our institutions. We have worked to build on the existing resources and expertise that each of our COBREs and IDeA-CTR provides to further increase our efficiencies and capacities at all institutions. We are appreciative to all of the faculty, staff, and students who have contributed to this joint endeavor and who have engaged in this knowledge-sharing effort. We hope that this partnership will increase future collaborations across our states and continue to grow our collective memberships. We look forward to continuing and expanding this unique partnership and aim to grow our successful COBRE-CTR collaboration with other substance use-focused centers across the US in the coming years.




TENTATIVE AGENDA: Please check back for updates.


Monday, November 9

  • Opening Remarks
  • Keynote 1: Kassandra Frederique
  • Panel Discussion on Harm Reduction

Tuesday, November 10

  • Lunch & Link-In (Networking Opportunity)
  • Short Research Presentations

Wednesday, November 11

  • Keynote 2: Judith Grisel
  • Poster Session
  • Panel Discussion on Stigma

Thursday, November 12

  • Coffee Connector (Networking Opportunity)
  • Short Research Presentations

Friday, November 13

  • Keynote 3
  • Panel Discussion on Community Engagement
  • Closing Remarks


 

This event is supported by the Rural Drug Addiction Research COBRE at the University of Nebraska-Lincoln [P20GM130461], the COBRE on Opioids and Overdose at Rhode Island Hospital [P20GM125507], and the West Virginia Clinical and Translational Science Institute [5U54GM104942-04]. All are funded by the National Institute of General Medical Sciences of the National Institutes of Health.

This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.